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Abstract
The research is dedicated to in-depth study of neurotrophic and antiepileptic properties of original potential anticonvulsant 
agents from 4-thiazolidinones – LES-2658 (5-(3-nitro-benzylidene)-2-(thiazol-2-ylimino)-thiazolidin-4-one) and LES-1205 ([2,4-dioxo- 
5-(thiazol-2-ylcarbamoylmethyl)-thiazolidin-3-yl]-acetic acid ethyl ester), synthesized at the Department of Pharmaceutical, Organic 
and Bioorganic Chemistry of Danylo Halytsky Lviv National Medical University, Ukraine. Studying of sleep – wakefulness cycle char-
acteristics in animals with chronic epileptic syndrome in conditions of 4-thiazolidinones derivatives LES-2658 and LES-1205 use was 
performed. The kindling syndrome was induced in Wistar rats via daily pentylenetetrazol (PTZ) (30 mg/kg, i. p.) administrations during 
three weeks and sleep – wakefulness cycle was studied under conditions of LES-2658 and LES-1205 administrations at doses 25.0 and 
100.0 mg/kg i. p.. Total wakefulness, non - rapid eye movement sleep, rapid eye movement sleep, falling asleep latency, REM – onset 
latency and also number of REM sleep episodes have been determined by behavioral characteristics of experimental animals. It 
was established that 4-thiazolidinone derivatives Les-1205 and Les-2658 reduce REM sleep fragmentation and increase its dura-
tion in PTZ-kindled rats. Les-1205 compound at dose 100.0 mg/kg show a clear correcting influence on kindling – induced sleep 
disturbances.
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1. Introduction
Epilepsy is the most common neurological disorder and its prevalence worldwide is es-
timated at 0.5–1 % [1]. In most cases, pharmacotherapy is the only one method for satisfactory 
correction and control of convulsive states [2]. Despite the substantial progress in research and 
development of efficient anticonvulsants the search of new original anticonvulsant agents remains 
still open problem, especially in the context of pharmacoresistance and significant side effects 
under long use [3, 4].
The model of chronic epileptization of brain formed by repeated application of a subthresh-
old dose of pentylenetetrazol (PTZ) adequately reflects the signs of clinical forms of disease, in-
cluding the disorders of sleep – wakefulness cycle [5, 6]. The study of the cycle allows estimate the 
brain mechanisms that control anxiety, to solve which mechanisms ensure its individual phases and 
to assess the influence of pharmacological agents on brain structure [5, 6]. Despite the well – es-
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tablished relation between sleep and epilepsy [7], very few studies are available on the effect of an 
antiepileptic drug on the sleep – cycle. 
4-Thiazolidinone derivatives are promising compounds in modern pharmacology for 
search of potential neurotropic agents with low acute and neurotoxicity properties [8–12]. Some 
4-thiazolidinones demonstrate multi-level anticonvulsant activity with satisfactory toxicity 
parametrs in conditions of such screening models as pentylentetrazol (PTZ, metrazol) seizures, 
maximal electroshock test, rotorod test [8–12]. Earlier anticonvulsant activity of original 4-thi-
azolidinones Les-1205 – [2,4-dioxo-5-(thiazol-2-ylcarbamoylmetyl)-thiazolidin-3-yl]-acetic 
acid ethyl ester and Les-2658 – 5-(3-nitrobenziliden)-2-(thiazol-2-imino)-4-thiazolidinone 
(synthesized at the Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo 
Halytsky Lviv National Medical University) have been identified in our studies [13–16]. Until 
recently, the studying of influence on the sleep – wakefulness cycle characteristics in rats with 
chronic epileptic syndrome formed by PTZ kindling were not used for determination of 4-thi-
azolidinones anticonvulsant activity mechanisms.
2. Aim of research
The study of 4-thiazolidinone derivatives LES-2658 and LES-1205 influence on the 
sleep – wakefulness cycle characteristics in rats with chronic epileptic syndrome formed by 
pentylenetetrazol (PTZ) kindling. 
3. Material and methods
All investigative procedures and the animal facilities were conformed to the Guide of 
Care and Use of Laboratory Animals within European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other Scientific Purposes (Stratsburg: Counsil of 
Europe 18.03.1986) and Law of Ukraine “On protection of animals from cruelty” (21.02.2006). 
For the study were used 54 male rats in age 5-6 months and weight ~180–220 gr (Rattus 
Norvegicus Var. Alba, Wistar). The animals were divided into 7 groups: one control (intact 
animals) group (n=6) and six experimental groups. For animals of all experimental groups the 
kindling syndrome was induced via daily pentylenetetrazol (PTZ) (30 mg/kg, i. p.) administra-
tions during three weeks. Rats that the last three injections caused generalized tonic – clonic 
seizures were used for the experimental monitoring. The animals of experimental group I 
(n=9) were administered 0.9 % solution of NaCl; experimental group II (n=9) – animals were 
administered diazepam (“Gedeon Richter”, Hungary), at dose 1.5 mg/kg, i.p., 30 minutes be-
fore PTZ; experimental group III (n=7) and IV (n=8) – animals were administered LES-2658 
at doses 100.0 and 25.0 mg/kg respectively, i. p., 30 minutes before PTZ; experimental group V 
(n=7) and VI (n=8) – animals were administered LES-1205 at doses 100.0 and 25.0 mg/kg re-
spectively, I p., 30 minutes before PTZ. The severity of seizures was evaluated according to 
five-point scale [5]. The tested rats were individually continuously monitored during 4 hours 
after 24 hours of the last application of PTZ under free behavior conditions and with identical 
degree of noise and lighting. All recordings were taken between 11.00 a. m. and 3 p. m. for a 
total recording time of 240 min. Total wakefulness (TW); total non-rapid eye movement sleep 
(NREM); total rapid eye movement sleep (REM); falling asleep latency (FAL) and REM – on-
set latency (RL) and also number of REM sleep episodes (RSE) have been determined by 
behavioral characteristics of experimental animals [6]. The durations of total wakefulness, 
NREM and REM sleep were given in % compared to the overall experiment duration (100 %); 
FAL and RL in minutes. Data were analyzed using the statistical criteria – ANOVA + New-
mann-Keuls, and Mann-Whitney U-test. All values are expressed as means ± SEM. Differenc-
es were considered significant when: * p≤0.05. 
4. Results 
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Fig. 1. The durations of total wakefulness, NREM and REM sleep under Les-2568, Les-1205 and 
diazepam administration in kindled rats. All parameters are given in % compared to the overall 
experiment duration (100 %). # – P<0.05 compared to the control group and * – P<0.05 compared 
to the kindled animals
Fig. 2. The characteristics of falling asleep (FAL) and REM – onset (RL) latency under  
Les-2568, Les-1205 and diazepam administration in kindled rats.  
* – P<0.05 compared to the kindled animals
Fig. 3. The number of REM sleep episodes (RSE) under Les-2568, Les-1205 and diazepam 
administration in kindled rats. # – P<0.05 compared to the control group and  
* – P<0.05 compared to the kindled animals
5. Discussion
The tendency to elongation of NREM sleep was observed in kindled rats. Its duration was 
65.29±8.79 % and exceeded similar in the control group by 7.9 % (P>0.05) (Fig. 1). At the same 
time, duration of REM sleep decreased by 38.4 % and was 9.04±2.84 % with statistically signifi-
cant (P=0.015). Furthermore the tendency to decrease of FAL by 20.1 % (25.1±9.48 min) as well 
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group I (Fig. 2). Also, the number of RSE increased by 65.8 % (to 20.44±5.46) and was statistically 
significant with P<0.05 (Fig. 3).
It was established that administration of referenced drug and tested compounds LES-2658 
and LES-1205 provoke changes in the in sleep pattern of kindled rats too.
The TW period was 19.6±5.94 % and decreased by 23.6% (P>0.05) as well as NREM 
sleep duration was 61.4±7.91 % and increased by 6.05 % (P>0.05) compared to kindled rats in 
rats when the diazepam was administrated at dose 1.5 mg/kg, i. p.. The duration of REM sleep 
was 11.45±2.06 % and increased by 26.6 % (P>0.05) but remained lower in comparison of intact 
rats group by 22.0 % (P>0.05) (Fig. 1). Also, FAL and RL were 19.69±6.48 min (P=0.021) and 
31.31±8.36 min (P<0.05) and increased by 37.3 % and by 39.1 % respectively compared to the con-
trol group (Fig. 2). The number of RSE was 1.56 times higher (19.25±4.79) in comparison to the 
intact rats group (P=0.06) (Fig. 3). 
When the LES-2658 was administrated at dose 100.0 mg/kg, i. p., duration of TW and REM 
sleep were 26.46±9.69 % (P>0.05) and 9.43±3.11 % (P<0.05) and increased by 3.1 % and by 
26.6 % respectively (Fig. 1). While NREM sleep duration was 64.11±7.87 % and decreased 
by 1.8 % (P>0.05) compared to kindled rats. Also, FAL and RL were 33.86±13.36 min and 
49.14±9.82 min and increased by 34.9 % and by 21.6 % (P>0.05 for all) respectively (Fig. 2). 
While the number of RSE was 17.43±3.10 and decreased by 14.7 % (P>0.05) compared to the 
kindled rats (Fig. 3). In case, when the LES-2658 was administrated at dose 25.0 mg/kg, i. p., 
duration of TW was 20.25±7.43 % and decreased by 21.9 % (P>0.05) in comparison of kin-
dled rats (Fig. 1). While the NREM sleep duration was 72.31±6.14 % and increased by 10.7 % 
(P>0.05) compared to kindled rats and was higher than the same indicator in intact rats by 
19.5 % (P = 0.043). Duration of REM sleep was 8.61±2.27 % (P<0.05) and remained lower by 
41.4 % compared to the intact rats (Fig. 1). 
Application of the Les-1205 at dose 100.0 mg/kg caused an increase TW duration (28.51±8.48 %) 
compared to kindled rats by 11.1 % (P>0.05) and compared to the II experimental group (diazepam 
used) by 45.5 % (P<0.05) (Fig. 1). Herewith the duration of NREM sleep phase was 58.4±9.0 % 
and slightly decreased by 10.6 % (P>0.05). The duration of the REM sleep was 12.94±2.58 % and 
increased by 43.1 % (P<0.05) (Fig. 1). Under these conditions, FAL and RL were 29.64±7.75 min and 
45.0±13.06 min (P>0.05 for all) increased by 18.1 % and by 11.4 % respectively (Fig. 2). Also, the 
number of RSE was 14.57±3.73 decreased significantly by 28.8 % with P<0.05 (Fig. 3). When the 
Les-1205 was administrated at dose 25.0 mg/kg, i. p., duration of REM sleep phase was 10.57±2.51 % 
and increased by 16.9 % (P>0.05). Also, RL was 42.35±11.29 min decreased by 8.9 %, (P>0.05) in 
comparison of II experimental group (Fig. 1, 3).
For PTZ-induced kindling model such effects as decreasing of total sleep duration and in-
creasing of its fragmentation were characteristic. These experimental results coincide with the 
research of other authors [4, 17, 18]. 
The use of 4-tiazolidinone derivative Les-1205 at dose 100.0 mg/kg in above-mentioned 
model of disorders of sleep – wakefulness cycle provoke opposite effects and is accompanied 
with increasing of the total sleep duration and decreasing of the number of its fragments. But 
for the derivative Les-2568 similar action was not observed and that can be explained by its less 
neurotrophic activity [8, 11]. 
Comparing of the impact of tested compounds with effects of diazepam showed that the 
for diazepam action was more typical reduction of FAL and RL in kindled rats and these data co-
incide with the results of other authors [19, 20]. Herewith, there was not observed an influence of 
diazepam on the REM sleep characteristics. The total duration of REM sleep was reduced and the 
number of fragments increased although was not statistically significant compared to the kindled 
rats group. Hence, this fact is in favor for opposite action of tested compounds and diazepam upon 
some components of sleep – wakefulness cycle. 
So, the obtained and presented results on influence of 4-thiazolidinone derivatives Les-2658 
and Les-1205 on sleep – wakefulness cycle in kindled rats cannot pretend to be the full solution of 
the search for new anticonvulsant agents. It is an attempt of studying and understanding anticon-
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vulsant mechanisms and properties of 4-thiazolidinones as possible drug. And these results are 
promising for in depth-study using other different experimental seizure models.
6. Conclusion
1. Under developed kindling conditions the wakefulness and REM sleep phases were de-
creased while at one time NREM sleep phase was increased. Moreover there are reducing REM-on-
set latency and increasing fragmentation of REM sleep phase.
2. 4-Thiazolidinone derivatives Les-1205 and Les-2658 reduce REM sleep fragmentation 
and increase its duration in PTZ-kindled rats and compound Les-1205 at dose 100.0 mg/kg 
has been shown a clear correcting influence on kindling – induced sleep disturbances while 
diazepam at dose 1.5 100.0 mg/kg does not cause any corrective influence on the REM sleep of 
kindled rats. 
3. Such ability of tested 4-thiazolidinones to recover of REM sleep parameters may indicate 
on importance in the implementation of anticonvulsant activity realization of this class of chemical 
compounds. 
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